Killer Cups?

Heavy coffee drinkers under 55 are more likely to die sooner, a study shows.

kerry grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, HENDRIKE Big-time coffee drinkers—those who consume at least four cups a day—have a greater chance of dying earlier than people who don't imbibe as much. That's according to a study published in Mayo Clinic Proceedings this week (August 15). The findings only apply to heavy coffee drinkers under the age of 55, and they serve to add to the jumble of conflicting results about the health impacts of coffee. “There continues to be considerable debate about the health effects of caffeine, and coffee specifically, with some reports suggesting toxicity and some even suggesting beneficial effects,” Carl Lavie, one of the study’s authors and a cardiologist at Ochsner Medical Center in New Orleans, said in a press release.

Lavie’s study included more than 43,000 participants, who were typically followed for 17 years. During that time, around 2,500 people died. After taking several confounding variables into account, the researchers found that men under 55 who drank at least 28 cups of coffee per week were 56 percent more likely to have died during the study than men who drank less. Women under 55, meanwhile, were a little more than twice as likely to have died than women who didn't drink as much coffee.

It’s not clear what might be driving this association. The findings were for all-cause mortality, rather than for any particular condition, such as heart disease. The researchers hesitantly pointed to genetics and addiction as possible culprits. “We hypothesize that the positive ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours